Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04230954
Title Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of South Alabama
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field